Scientist.com, the life sciences industry’s leading AI-enabled R&D orchestration platform and digital marketplace, and AGC Pharma Chemicals, a leading global Contract Development and Manufacturing Organization (CDMO) for small molecule API and HPAPI, announced today that AGC has successfully completed an onsite assessment of its new Barcelona facility using the VERIF.i® supplier pre-assessment program.
The newly expanded Barcelona site strengthens AGC’s position as a global leader in the development and commercialization of complex small molecule Active Pharmaceutical Ingredients (APIs) and highly potent APIs (HPAPIs). Designed for maximum flexibility, safety, and energy efficiency, the facility expands AGC’s end-to-end capabilities from gram-scale to ton-scale production under the highest quality and sustainability standards.
“At AGC Pharma Chemicals, we place the highest priority on the integrity of our operational processes and the expertise of our frontline teams,” said Jun Kurihara, CEO of AGC Pharma Chemicals. “By leveraging VERIF.i to demonstrate our adherence to international management standards and the robustness of our production oversight, we reinforce our transparent and unwavering commitment to quality for our customers.”
VERIF.i was developed to provide suppliers of regulated research services—including chemistry, manufacturing, and controls (CMC)—with a platform to proactively communicate their capabilities against established industry criteria. These onsite pre-assessments are conducted by independent, third-party auditors to ensure the integrity and objectivity of the site visit.
“When sourcing regulated services with high reputational risk, resource-intensive onsite pre-assessments are a critical component of the due diligence process,” stated Matt McLoughlin, SVP of Compliance & Categories at Scientist.com. “VERIF.i creates a standardized process that addresses these barriers for both sides, saving time and resources while allowing high-caliber suppliers like AGC Pharma Chemicals to differentiate themselves through independent, actionable insights into their facilities and personnel.” The program helps pharmaceutical and biotech customers accelerate the procurement of regulated services with increased confidence and reduced risk. VERIF.i is an expansion of Scientist.com’s award-winning COMPLi® solution.
For more information, please visit https://www.scientist.com/platform/regulatory-compliance
